[ad_1]
Marksans Pharma Restricted, India is voluntarily recalling Metformin Hydrochloride Prolonged-Launch Tablets, USP 500mg, lot # XP9004, to the buyer degree. FDA evaluation has discovered the product to comprise N-Nitrosodimethylamine (NDMA) ranges in extra of the Acceptable Each day Consumption Restrict (ADI) of 96ng/da
[ad_2]
Source link
Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
Related Posts
Add A Comment